Ibrutinib in Combination with Revlimid/Dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma (AFT-15)
- Citation:
- Blood vol 41 (Supplement 1) 3340
- Meeting Instance:
- ASH 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Pharmacyclics
- Grants:
- Corr. Author:
- Authors:
- Yvonne Efebera Vera Suman Shira Dinner Ashley Rosko John Mckay Peter Barth Patrick Hagen Saad Usmani Paul Richardson Jacob Laubach
- Networks:
- IL017, LAPS-IL036, LAPS-MA036, LAPS-NY016, LAPS-OH007, NC002, OH008, RI005
- Study
- AFT-15
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: